FI980463A0 - Sjaelvreplikerande vektor foer DNA-immunisering mot HIV - Google Patents

Sjaelvreplikerande vektor foer DNA-immunisering mot HIV

Info

Publication number
FI980463A0
FI980463A0 FI980463A FI980463A FI980463A0 FI 980463 A0 FI980463 A0 FI 980463A0 FI 980463 A FI980463 A FI 980463A FI 980463 A FI980463 A FI 980463A FI 980463 A0 FI980463 A0 FI 980463A0
Authority
FI
Finland
Prior art keywords
sjaelvreplikerande
hiv
vector
dna immunization
immunization
Prior art date
Application number
FI980463A
Other languages
English (en)
Other versions
FI105105B (fi
FI980463A (fi
Inventor
Marja Taehtinen
Paert Peterson
Kai Krohn
Paeivi Annamari Ranki
Original Assignee
Finnish Immunotechnology Ltd O
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Finnish Immunotechnology Ltd O filed Critical Finnish Immunotechnology Ltd O
Publication of FI980463A0 publication Critical patent/FI980463A0/fi
Priority to FI980463A priority Critical patent/FI105105B/fi
Priority to RU2000122617/13A priority patent/RU2232815C2/ru
Priority to EP99906279A priority patent/EP1056879A1/en
Priority to APAP/P/2000/001892A priority patent/AP2000001892A0/en
Priority to OA1200000232A priority patent/OA11528A/en
Priority to AU26266/99A priority patent/AU2626699A/en
Priority to CN99804629A priority patent/CN1295623A/zh
Priority to PCT/FI1999/000152 priority patent/WO1999043841A1/en
Publication of FI980463A publication Critical patent/FI980463A/fi
Application granted granted Critical
Publication of FI105105B publication Critical patent/FI105105B/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16311—Human Immunodeficiency Virus, HIV concerning HIV regulatory proteins
    • C12N2740/16322—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2800/00—Nucleic acids vectors
    • C12N2800/10—Plasmid DNA
    • C12N2800/108—Plasmid DNA episomal vectors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00—Vector systems having a special element relevant for transcription
    • C12N2830/42—Vector systems having a special element relevant for transcription being an intron or intervening sequence for splicing and/or stability of RNA
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2840/00—Vectors comprising a special translation-regulating system
    • C12N2840/20—Vectors comprising a special translation-regulating system translation of more than one cistron

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Virology (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Biophysics (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Physics & Mathematics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Plant Pathology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Microbiology (AREA)
  • AIDS & HIV (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
FI980463A 1998-02-27 1998-02-27 Itsereplikoiva DNA-vektori immunisoimiseksi HIV:ta vastaan FI105105B (fi)

Priority Applications (8)

Application Number Priority Date Filing Date Title
FI980463A FI105105B (fi) 1998-02-27 1998-02-27 Itsereplikoiva DNA-vektori immunisoimiseksi HIV:ta vastaan
OA1200000232A OA11528A (en) 1998-02-27 1999-02-26 Self-replicating vector for DNA immunization against HIV.
EP99906279A EP1056879A1 (en) 1998-02-27 1999-02-26 Self-replicating vector for dna immunization against hiv
APAP/P/2000/001892A AP2000001892A0 (en) 1998-02-27 1999-02-26 Self-replicating vector for DNA immunization against HIV.
RU2000122617/13A RU2232815C2 (ru) 1998-02-27 1999-02-26 Самореплицирующийся рекомбинантный вектор, экспрессирующий регуляторные белки вич, способ его получения, вакцина для иммунизации против вич на основе днк, содержащая указанный вектор, способ лечения или профилактики вич
AU26266/99A AU2626699A (en) 1998-02-27 1999-02-26 Self-replicating vector for dna immunization against hiv
CN99804629A CN1295623A (zh) 1998-02-27 1999-02-26 用于抗hiv之dna免疫的自我复制的载体
PCT/FI1999/000152 WO1999043841A1 (en) 1998-02-27 1999-02-26 Self-replicating vector for dna immunization against hiv

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FI980463A FI105105B (fi) 1998-02-27 1998-02-27 Itsereplikoiva DNA-vektori immunisoimiseksi HIV:ta vastaan
FI980463 1998-02-27

Publications (3)

Publication Number Publication Date
FI980463A0 true FI980463A0 (fi) 1998-02-27
FI980463A FI980463A (fi) 1999-09-27
FI105105B FI105105B (fi) 2000-06-15

Family

ID=8551073

Family Applications (1)

Application Number Title Priority Date Filing Date
FI980463A FI105105B (fi) 1998-02-27 1998-02-27 Itsereplikoiva DNA-vektori immunisoimiseksi HIV:ta vastaan

Country Status (8)

Country Link
EP (1) EP1056879A1 (fi)
CN (1) CN1295623A (fi)
AP (1) AP2000001892A0 (fi)
AU (1) AU2626699A (fi)
FI (1) FI105105B (fi)
OA (1) OA11528A (fi)
RU (1) RU2232815C2 (fi)
WO (1) WO1999043841A1 (fi)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI107737B (fi) * 1999-12-23 2001-09-28 Atso Raasmaja Plasmidi tyrosiinihydroksylaasigeenin ilmentämiseksi aivoissa
FI116851B (fi) 2001-05-03 2006-03-15 Fit Biotech Oyj Plc Ilmentämisvektori, sen käyttöjä ja menetelmä sen valmistamiseksi sekä sitä sisältäviä tuotteita
EP1279404A1 (en) * 2001-07-26 2003-01-29 Istituto Superiore di Sanità Use of HIV-1 tat, fragments or derivatives thereof, to target or to activate antigen-presenting cells, to deliver cargo molecules for vaccination or to treat other diseases
DK1506223T3 (da) 2002-05-16 2006-04-10 Bavarian Nordic As Fusionsprotein af regulatoriske/accessoriske HIV-proteiner
KR101471043B1 (ko) * 2009-01-08 2014-12-09 주식회사 바이오리더스 안정적인 항시적 고발현 자궁경부암 치료백신용 벡터 및 그에 의해 형질전환된 재조합 유산균
US10246509B2 (en) * 2011-10-17 2019-04-02 Regeneron Pharmaceuticals, Inc. Restricted immunoglobulin heavy chain mice
CN109640946A (zh) * 2016-06-03 2019-04-16 天普大学-联邦高等教育系统 通过基因编辑策略进行hiv-1的负反馈调节
CN110747214B (zh) * 2019-03-13 2021-12-31 深圳市臻质医疗科技有限公司 DNA片段、具有长效表达和细胞特异性结合能力的mRNA-抗体融合分子及其制备方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU1138897A (en) * 1995-12-29 1997-07-28 Estonian Biocentre Episomal vector and uses thereof

Also Published As

Publication number Publication date
AP2000001892A0 (en) 2000-09-30
FI105105B (fi) 2000-06-15
EP1056879A1 (en) 2000-12-06
OA11528A (en) 2004-05-07
AU2626699A (en) 1999-09-15
FI980463A (fi) 1999-09-27
WO1999043841A1 (en) 1999-09-02
RU2232815C2 (ru) 2004-07-20
CN1295623A (zh) 2001-05-16

Similar Documents

Publication Publication Date Title
DE69819441D1 (de) Gezackte Schubdüse
DE69840172D1 (de) Rna exportelement
NO976060D0 (no) Vaksiner mot hepatitt C
DK1561458T3 (da) Hurtigt henfaldende fast middel
IT1304321B1 (it) Mezzi contenitori
ID16021A (id) Gen-gen hiv sintetis
DE59800452D1 (de) Lagerstabile, permanent wasserbenetzbare, vulkanisate ergebende polysiloxanmasse
GB9826069D0 (en) HIV vaccine
NO973319A (no) Sammenleggbar dybdekontroller
ZA992478B (en) Adjuvant-containing dna vaccines.
FR2781876B1 (fr) Charge propulsive
FI980463A0 (fi) Sjaelvreplikerande vektor foer DNA-immunisering mot HIV
FI20002413A0 (fi) Sähkömoottorikäyttöinen kulkulaite
IT1306854B1 (it) Autoveicolo con capote apribile.
ATE358175T1 (de) Poly(adp-ribose)polymerase-gene
AU2001246703A1 (en) Dna immunization vectors
ID28046A (id) Vektor propionibacterium
HUP0101652A3 (en) Hepatitis vaccine
GB9704977D0 (en) FIV vaccine
ZA98830B (en) Infectious bursitis vaccine.
ATE431415T1 (de) Hiv impfstoff
GB0030060D0 (en) Propulsion system
ITMI981384A0 (it) Vaccino per hiv
AU6366001A (en) Propulsion system
SE9604743D0 (sv) Pile driver

Legal Events

Date Code Title Description
MA Patent expired